Department of Surgery, University of California, Los Angeles, CA, USA.
Eur J Cardiothorac Surg. 2012 May;41(5):1132-7. doi: 10.1093/ejcts/ezr315. Epub 2012 Mar 6.
Despite advanced cardiac life support (ACLS), the mortality from sudden death after cardiac arrest is 85-95%, and becomes nearly 100% if ischaemia is prolonged, as occurs following unwitnessed arrest. Moreover, 33-50% of survivors following ACLS after witnessed arrest develop significant neurological dysfunction, and this rises to nearly 100% in the rare survivors of unwitnessed arrest. Although, whole body (cardiac) survival improves to 30% following recent use of emergency cardiopulmonary bypass, sustained neurological dysfunction remains a devastating and unresolved problem. Our studies suggest that both brain and whole body damage reflect an ischaemic/reperfusion injury that follows the present reperfusion methods that use normal blood, which we term 'uncontrolled reperfusion'. In contrast, we have previously introduced the term 'controlled reperfusion', which denotes controlling both the conditions (pressure, flow and temperature) as well as the composition (solution) of the reperfusate. Following prolonged ischaemia of the heart, lung and lower extremity, controlled reperfusion resulted in tissue recovery after ischaemic intervals previously thought to produce irreversible cellular injury. These observations underlie the current hypothesis that controlled reperfusion will become an effective treatment of the otherwise lethal injury of prolonged brain ischaemia, such as with unwitnessed arrest, and we tested this after 30 min of normothermic global brain ischaemia. This review, and the subsequent three studies will describe the evolution of the concept that controlled reperfusion will restore neurological function to the brain following prolonged (30 min) ischaemia. To provide a familiarity and rationale for these studies, this overview reviews the background and current treatment of sudden death, the concepts of controlled reperfusion, recent studies in the brain during whole body ischaemia, and then summarizes the three papers in this series on a new brain ischaemia model that endorses our hypothesis that controlled reperfusion allows complete neurological recovery following 30 min of normothermic global brain ischaemia. These findings may introduce innovative management approaches for sudden death, and perhaps stroke, because the brain is completely salvageable following ischaemic times thought previously to produce infarction.
尽管采用了先进的心脏生命支持 (ACLS),但心脏骤停后猝死的死亡率仍为 85-95%,如果缺血时间延长,如在无人见证的情况下发生心脏骤停,则几乎达到 100%。此外,在有目击者的情况下进行 ACLS 后,33-50%的幸存者会出现明显的神经功能障碍,而在无人见证的情况下幸存者中,这一比例几乎达到 100%。尽管最近使用急诊心肺旁路术可使全身(心脏)存活率提高到 30%,但持续的神经功能障碍仍然是一个毁灭性且尚未解决的问题。我们的研究表明,大脑和全身损伤均反映出目前使用正常血液的再灌注方法所导致的缺血/再灌注损伤,我们称之为“不受控制的再灌注”。相比之下,我们之前引入了“受控再灌注”一词,该词表示既可以控制再灌注条件(压力、流量和温度),也可以控制再灌注液的组成(溶液)。在心脏、肺和下肢长时间缺血后,受控再灌注导致以前认为会产生不可逆细胞损伤的缺血间隔后的组织恢复。这些观察结果为当前的假设提供了依据,即受控再灌注将成为治疗长时间脑缺血(如无人见证的心脏骤停)的有效方法,我们在 30 分钟的体温正常性全脑缺血后对其进行了测试。本综述以及随后的三项研究将描述受控再灌注将恢复长时间(30 分钟)缺血后大脑神经功能的概念的演变。为了使这些研究更加熟悉和合理,本综述回顾了突发性死亡的背景和当前治疗方法、受控再灌注的概念、全身缺血期间大脑的最新研究,然后总结了本系列中的三篇论文,介绍了一种新的脑缺血模型,该模型支持我们的假设,即受控再灌注可使 30 分钟体温正常性全脑缺血后的神经功能完全恢复。这些发现可能为突发性死亡,也许还为中风,引入创新的管理方法,因为大脑在以前认为会导致梗死的缺血时间后仍然完全可挽救。